Emerade 0.5 mg (Epinephrine (Epinephrine Bitartrate) SOLUTION) 0.5 MG

Emerade 0.5 mg is an epinephrine auto-injector designed for emergency use. This solution provides rapid relief in severe allergic reactions, offering quick administration for critical situations.

Strength

0.5 MG

Pack Size

0.5ML

Manufacturer / TM Owner

BAUSCH HEALTH, CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Emerade 0.5 mg is primarily used for the emergency treatment of severe allergic reactions, including anaphylaxis. It contains epinephrine, which helps to counteract life-threatening symptoms such as difficulty breathing, swelling, and low blood pressure. This medication is often carried by individuals with known allergies to ensure prompt treatment when needed.

Side Effects

Emerade 0.5 mg works by quickly delivering epinephrine into the muscle to relieve severe allergic symptoms. Users may experience temporary effects such as increased heart rate, nervousness, or tremors. These effects are generally short-lived and indicate the medication is working as intended.

Precautions & Warnings

Emerade 0.5 mg should be used with caution and only in emergency situations. It is important to follow proper administration techniques and seek medical attention immediately after use. Store the auto-injector at room temperature and avoid exposure to extreme temperatures.

Avoid Interactions

Emerade 0.5 mg may interact with certain medications, including beta-blockers, antidepressants, and other drugs that affect the heart or blood pressure. Always inform healthcare providers about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Emerade 0.5 mg is used for the emergency treatment of severe allergic reactions, including anaphylaxis.

Emerade 0.5 mg delivers epinephrine into the muscle to quickly relieve severe allergic symptoms.

Common side effects may include increased heart rate, nervousness, and tremors.

Store Emerade 0.5 mg at room temperature and avoid exposure to extreme temperatures.

Emerade 0.5 mg may interact with certain medications, so it's important to consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.